title: Codon 72 polymorphism of TP53 gene is a novel prognostic marker for therapy in multiple myeloma.
authors.affiliation: Division of Clinical Physiology and Therapeutics, Keio University Faculty of Pharmacy, Tokyo, Japan. hattori-yt@pha.keio.ac.jp.
authors.forename: Yutaka
authors.initials: Y
authors.lastname: Hattori
authors.forename: Yurika
authors.initials: Y
authors.lastname: Ikeda
authors.forename: Yuya
authors.initials: Y
authors.lastname: Suzuki
authors.forename: Daiju
authors.initials: D
authors.lastname: Ichikawa
authors.forename: Maiko
authors.initials: M
authors.lastname: Matsushita
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D003062:Codon / Q000235:genetics; D005260:Female; D016158:Genes, p53 / Q000235:genetics*; D006801:Humans; D053208:Kaplan-Meier Estimate; D008297:Male; D008875:Middle Aged; D009101:Multiple Myeloma / Q000235:genetics*; D011110:Polymorphism, Genetic; D011379:Prognosis; D016896:Treatment Outcome
chemical_list: D003062:Codon
keywords: codon 72 polymorphism of TP53; multiple myeloma; prognosis; thalidomide